Company: NIVFW
Filing Date: 2025-06-03
Form Type: 424B3
Source: 0001213900-25-050825
Chunk: 101

Company: NewGenIvf Group Ltd
Filing Date: 2025-06-03
Form: 424B3
Chunk 101
---
 the outstanding amounts due pursuant to the terms and conditions of the
repayment agreement dated August 14, 2023. As of December 31, 2024, the aggregate balance of amount due to Mr. Siu and Ms. Fong was US$92,651.

In addition, NewGenIvf
also recorded remuneration to its directors, Mr. Siu and Ms. Fong. The remuneration to Mr. Siu, Wing Fung Alfred was US$125,000 and US$190,000
during the year ended December 31, 2023 and 2024, respectively. The remuneration during the years ended December 31, 2023 and 2024 was
all in the nature of the fair value of the services provided by Mr. Siu and Ms. Fong. Mr. Siu Wing Fung also entered into agreement to
waive the balance of due from the Company US$88,151 in 2023.

<div align='center'>59

LISTING DETAILS</div>

Our Class A Ordinary Shares
currently trade on Nasdaq under the symbol “NIVF.” As of the date of this prospectus, our only listed class of securities
are our Class A Ordinary Shares. All of our Class A Ordinary Shares, including those to be offered by the Selling Securityholder pursuant
to this prospectus, have the same rights and privileges. For more information, see “Description of Share Capital—Ordinary Shares.”

<div align='center'>USE OF PROCEEDS</div>

All of the Resale Shares
will be sold by the Selling Securityholders for their own accounts. We will not receive any proceeds from the resale of the Resale Shares.
However, we may receive gross proceeds of up to $500 million from the sale of our Ordinary Shares to White Lion pursuant to the White
Lion Purchase Agreement. The actual proceeds from White Lion may be less than this amount, depending on the number of Class A Ordinary
Shares sold and the price at which the Class A Ordinary Shares are sold. In addition, we may receive proceeds of up to $42,433,500 from
the conversion of the Additional Notes, Exchange Notes, Warrants, New CB Initial Note which proceeds will be used for working capital
and other general corporate purposes. We will also bear the costs incurred in connection with this prospectus and the registration of
the Resale Shares.

<div align='center'>DIVIDEND POLICY</div>